Cykel AI PLC Rule 2.9 Announcement - Supplement

RNS Number : 9608A

Cykel AI PLC

25 January 2024

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

For immediate release

25 January 2024

Cykel AI PLC

("Cykel" or the "Company")

Rule 2.9 Announcement - Supplement

Further to the announcement made on 19 January 2024, in accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the "Code"), the Company confirms that, in addition to its 205,183,350 ordinary shares of 0.1 pence each in issue in the Company, as at the date and time of this announcement, there are warrants to subscribe for 59,385,170 ordinary shares of 0.1 pence each in the Company as follows: (i) 48,000,000 warrants are exercisable at 1 pence per share until 25 October 2026; and (ii) 11,385,170 warrants are exercisable at 3 pence per share until 25 October 2028.

The ISIN reference number for the ordinary shares in the Company is GB00BPTJZN05.

The individual responsible for releasing this announcement is Nicholas Lyth.

Enquiries:

Cykel AI PLC
Jonathan Bixby	Via First Sentinel
Capital Plus Partners
Dominic Berger	[e-mail]   [phone]
First Sentinel (Corporate Adviser)
Brian Stockbridge	[e-mail]     [phone]
Clear Capital Markets (Broker)
Bob Roberts	[phone]

LEI Number: 9845003CB9FEA73A3E09

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXBUGDBCSDDGSU